Derio, Spain · Founded 2009 · Privately Held (backing)
Developer of stroma-targeted precision drugs and diagnostics intended to fight against invasive tumours. Oncomatryx Biopharma is based in Derio, Spain and was founded in 2009. Its last reported valuation was $112 million in Mar 2022. It has raised $146 million.
Last reported valuation
$111.8M
Oct 2026
Priced at
—
Total raised
$146.0M
Last round
—
Cap table — not yet on record
Oncomatryx Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Oncomatryx Biopharma with a free account
·Watch Oncomatryx Biopharma: the Monday email on marks, rounds and moves
